These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16702925)

  • 1. [The role of podocytes in normal glomerular function and in the pathogenesis of glomerulonephritis. Part II. Phenotypic and functional changes of podocytes in glomerulonephritis].
    Kubiak A; Niemir ZI
    Postepy Hig Med Dosw (Online); 2006; 60():259-64. PubMed ID: 16702925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of podocytes in normal glomerular function and in the pathogenesis of glomerulonephritis. Part I. Phenotypic and functional characteristics of podocytes during their differentiation and maturity].
    Kubiak A; Niemir ZI
    Postepy Hig Med Dosw (Online); 2006; 60():248-58. PubMed ID: 16702924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular podocytes and adhesive interaction with glomerular basement membrane.
    Mundel P; Shankland SJ
    Exp Nephrol; 1999; 7(2):160-6. PubMed ID: 10213869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L; Kopp JB
    Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Podocyte depletion in children with hepatitis B virus-associated membranous nephropathy].
    Zhang Y; Zhou JH; Wang HT
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):344-8. PubMed ID: 17697619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte biology and the emerging understanding of podocyte diseases.
    Barisoni L; Mundel P
    Am J Nephrol; 2003; 23(5):353-60. PubMed ID: 12915777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes.
    Eyre J; Burton JO; Saleem MA; Mathieson PW; Topham PS; Brunskill NJ
    Nephron Exp Nephrol; 2011; 119(3):e58-66. PubMed ID: 21849801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
    Embry AE; Liu Z; Henderson JM; Byfield FJ; Liu L; Yoon J; Wu Z; Cruz K; Moradi S; Gillombardo CB; Hussain RZ; Doelger R; Stuve O; Chang AN; Janmey PA; Bruggeman LA; Miller RT
    J Am Soc Nephrol; 2018 May; 29(5):1501-1512. PubMed ID: 29572404
    [No Abstract]   [Full Text] [Related]  

  • 11. Parietal epithelial cells and podocytes in glomerular diseases.
    Smeets B; Moeller MJ
    Semin Nephrol; 2012 Jul; 32(4):357-67. PubMed ID: 22958490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Players: Cells Involved in Glomerular Disease.
    Kitching AR; Hutton HL
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1664-1674. PubMed ID: 27073196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Glomerular Barrier Dysfunction with Patient-Derived Serum in Glomerulus-on-a-Chip Models: Unveiling New Insights into Glomerulonephritis.
    Kim SY; Choi YY; Kwon EJ; Seo S; Kim WY; Park SH; Park S; Chin HJ; Na KY; Kim S
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
    Shankland SJ
    Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
    Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
    J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte and Parietal Epithelial Cell Interactions in Health and Disease.
    Al Hussain T; Al Mana H; Hussein MH; Akhtar M
    Adv Anat Pathol; 2017 Jan; 24(1):24-34. PubMed ID: 27677082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FYVE domain-containing protein ZFYVE28 regulates EGFR-signaling in podocytes but is not critical for the function of filtration barrier in mice.
    Zambrano S; Rodriguez PQ; Guo J; Möller-Hackbarth K; Schwarz A; Patrakka J
    Sci Rep; 2018 Mar; 8(1):4712. PubMed ID: 29549365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of podocytopathies: a unifying view of glomerular diseases.
    Wiggins RC
    Kidney Int; 2007 Jun; 71(12):1205-14. PubMed ID: 17410103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.